This is a Validated Antibody Database (VAD) review about rat Mark4, based on 3 published articles (read how Labome selects the articles), using Mark4 antibody in all methods. It is aimed to help Labome visitors find the most suited Mark4 antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
Knockout validation
Cell Signaling Technology
domestic rabbit polyclonal
  • western blot knockout validation; human; loading ...; fig 3b
Cell Signaling Technology Mark4 antibody (Cell Signaling, 4834) was used in western blot knockout validation on human samples (fig 3b). EMBO Rep (2017) ncbi
Cell Signaling Technology
domestic rabbit polyclonal
  • immunohistochemistry - paraffin section; human; 1:200; fig 8f
  • western blot; human; 1:1000; loading ...; fig 3h
Cell Signaling Technology Mark4 antibody (CST, 4834) was used in immunohistochemistry - paraffin section on human samples at 1:200 (fig 8f) and in western blot on human samples at 1:1000 (fig 3h). Nat Commun (2022) ncbi
domestic rabbit polyclonal
  • proximity ligation assay; mouse; loading ...; fig s8a
Cell Signaling Technology Mark4 antibody (Cell Signaling, 4834) was used in proximity ligation assay on mouse samples (fig s8a). Nat Commun (2017) ncbi
domestic rabbit polyclonal
  • western blot knockout validation; human; loading ...; fig 3b
Cell Signaling Technology Mark4 antibody (Cell Signaling, 4834) was used in western blot knockout validation on human samples (fig 3b). EMBO Rep (2017) ncbi
Articles Reviewed
  1. Yu B, Su J, Shi Q, Liu Q, Ma J, Ru G, et al. KMT5A-methylated SNIP1 promotes triple-negative breast cancer metastasis by activating YAP signaling. Nat Commun. 2022;13:2192 pubmed publisher
  2. Li X, Thome S, Ma X, Amrute Nayak M, Finigan A, Kitt L, et al. MARK4 regulates NLRP3 positioning and inflammasome activation through a microtubule-dependent mechanism. Nat Commun. 2017;8:15986 pubmed publisher
  3. Heidary Arash E, Shiban A, Song S, Attisano L. MARK4 inhibits Hippo signaling to promote proliferation and migration of breast cancer cells. EMBO Rep. 2017;18:420-436 pubmed publisher